U.S. healthcare group Johnson & Johnson is raising its offer for Swiss biotech company Actelion , a source familiar with the matter said on Tuesday.
Actelion was not immediately available for comment. The companies had confirmed last week they were in talks about a possible transaction.
Continue Reading Below
(Reporting by Pamela Barbaglia; Editing by Michael Shields)